Archives for December 2011

The Best of Highlight HEALTH 2011 – The Year in Review

December 30, 2011 | by Walter Jessen

This December (in fact just four days ago) Highlight HEALTH celebrated its fifth year promoting advances in biomedical research. To observe the event, for the next two months we’re holding prize pack giveaways.

Would you like to win two free books, two magazine subscriptions and a Webicina T-shirt? To enter the giveaway, simply subscribe to the Highlight HEALTH Network email updates.

As the year draws to a close, let’s take a look back at the top stories readers were interested in for 2011. We’ve compiled two top ten lists of the most-viewed stories for the year, one as measured by the absolute number of page views and the other as measured by the average number of page views per day posted.

[Continue Reading]

Is My Cancer Different? A Personalized Medicine Campaign

December 29, 2011 | by Walter Jessen

The Is My Cancer Different? campaign urges patients to ask their doctors a crucial question — is my cancer different? — and provides powerful information on why, when and how it could matter to their treatment choices.

Presented in video format and featuring cancer survivors, physicians, scientists, advocates and Ronnie Andrews, the president of Clarient, the personalized medicine campaign covers what indivdualized cancer treatment means, what makes a patient’s cancer different, treatment decisions, expert insights and more.

[Continue Reading]

Supplemental Vitamin E and A, Worth The Risk?

December 28, 2011 | by Kirstin Hendrickson

Perhaps among the most confusing of nutrition and wellness decisions that the average consumer must make is whether to take dietary supplements. The available information is deeply contradictory; while some supplements — like folic acid for pregnant women and vitamin D for babies — are considered nearly essential in medical care, research suggests that other supplements may be ineffective or even deleterious to health. A recent research summary published in The Medical Letter On Drugs and Therapeutics may help consumers and practitioners to wade through the conflicting information on supplements, as many supplements have both risks and benefits associated with their use [1].

[Continue Reading]

Open Source Drug Discovery for Malaria

December 28, 2011 | by Walter Jessen

The term “open source” describes practices in production and development that promote access to the end product’s source materials. I’m sure you’ve heard of open source software such as Perl, WordPress, Linux and Android, and are familiar with open content projects such as Wikipedia and Wiktionary, but what about open source drug discovery?

Specifically, Open Source Drug Discovery (OSDD) for Malaria is a project launched earlier this year by The Synaptic Leap (TSL), a non-profit organization for open source biomedical research. They focus on providing online tools to allow researchers to coordinate efforts and exchange knowledge. Project members can participate in online discussions, author blogs, and use aggregated RSS feeds to stay current with news and research.

Why malaria? Because malaria is one of the most serious public health problems in tropical and sub-tropical regions of the world.

Malaria is a potentially fatal blood disease caused by a human parasite called Plasmodium falciparum. Malaria is transmitted to human and animal hosts by the female anopheles mosquito. Although the disease can be treated in just 48 hours, it can cause fatal complications if the diagnosis and treatment are delayed.

Malaria is a disease of several different strains; five species of Plasmodium can infect and be transmitted by humans. Malaria is currently the fifth cause of death from infectious diseases worldwide, following respiratory infections, HIV/AIDS, diarrheal diseases, and tuberculosis, and the second cause of death in Africa, following HIV/AIDS.

OSDD Malara is a hub for global efforts in open source drug discovery for malaria. The initial participants of OSDD Malaria are the lab of Dr. Matthew Todd, an organic chemist, at the University of Sydney and the Medicines for Malaria Venture (MMV). Other participants in the project include scientists from the University of Melbourne and Griffith University in Australia, and GlaxoSmithKline in Madrid. As an open science project, anyone can come and join, and participation is encouraged at any level.

OSDD Malaria will be holding an open source drug discovery for malaria meeting in Sydney, Australia on February 24th, 2012. The meeting, like the organization’s data, is open to all and will hopefully be live-streamed to a global audience. The aim is to work out how best to do open source drug discovery. More details will be coming soon.

If you want to get involved, you can sign up for The Synaptic Leap updates (by joining), follow Matthew Todd on Google+ (where data is often presented), or follow the OSDD Malaria Twitter feed.

The OSDD Malaria project status is described on the OSDD Malaria wiki.